Deerfield Management Company, L.P. (Series C) Chimerix Inc Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.04 Billion
- Q4 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Chimerix Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 3,771,342 shares of CMRX stock, worth $32.1 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
3,771,342Holding current value
$32.1 Million% of portfolio
0.32%Shares
3 transactions
Others Institutions Holding CMRX
# of Institutions
77Shares Held
40.3MCall Options Held
243KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA8.8MShares$74.8 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.04MShares$34.4 Million0.0% of portfolio
-
Monaco Asset Management Sam2.82MShares$24 Million1.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.56MShares$21.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$19 Million0.11% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $745M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...